Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/1993
10/20/1993EP0398925B1 Growth inhibiting agent and the use thereof
10/19/1993US5254682 Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs
10/14/1993WO1993020047A1 Hydroxamic acid based collagenase and cytokine inhibitors
10/12/1993US5252605 Promotion of wound-healing with 15-keto-prostaglandin compounds
10/12/1993US5252591 Renin inhibitors
10/12/1993US5252574 Hypotensive agents, vision disorder
10/12/1993US5252571 Antidiabetic agents
10/12/1993CA2093785A1 Benzimidazoles
10/06/1993EP0564356A1 4-phenylaminomethylimidazole derivatives, process for their preparation, angiotensin II receptor antagonists and their application in therapy
10/06/1993EP0564216A2 Pharmaceutical compositions for the treatment and/or prevention of degenerative disorders in the retina
10/06/1993EP0563238A1 Imidazolyl-alkenoic acids
10/06/1993CN1022325C Azolidinedione derovatives
10/05/1993CA1322761C Organogermanium compounds and process for producing the same
10/05/1993CA1322752C Heteroarylcarboxamide derivatives, process for preparing the same and pharmaceutical composition containing the same
10/02/1993CA2093178A1 Pharmaceutical compositions for the treatment and/or prevention of degenerative disorders in the retina
10/02/1993CA2092852A1 Imidazole derivatives, their method of preparation and their application in therapeutic
09/1993
09/30/1993WO1993018777A1 Use of mannose phosphates for the treatment of fibrotic disorders
09/30/1993WO1993018772A1 Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists
09/30/1993WO1993018762A2 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists
09/30/1993CA2132102A1 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists
09/29/1993EP0562936A1 Imidazolines N-substituted by a biphenylmethyl group, their preparation, the pharmaceutical compositions containing them
09/29/1993EP0562006A1 Homo-prostaglandin derivatives as ocular hypotensives
09/29/1993EP0561913A1 Use of pyridine derivatives in the treatment of ocular hypertension
09/29/1993EP0561905A1 Use of angiotensin ii receptor antagonists in the treatment of macular degeneration
09/29/1993EP0561901A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
09/29/1993EP0561772A1 A new pharmaceutical use of fusidic acid and derivatives thereof
09/28/1993US5248693 Acetylene compounds and pharmaceutical compositions and methods of using the same
09/28/1993US5248504 Method of treatment for nasal and sinus dysfunction
09/28/1993CA1322526C Chemical prevention or reversal of cataract by phase separation inhibitors
09/28/1993CA1322524C Method and composition for ophthalmic anesthesia using rodocaine
09/21/1993US5246944 Hypotensive and anxiolytic agents; antidepressants
09/21/1993US5246940 Substituted n-biphenylyl lactams
09/21/1993CA1322332C Protein c inhibitor (pci) as pharmaceutical and diagnostic aid a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci
09/21/1993CA1322328C Stabilized compositions containing epidermal growth factor
09/16/1993WO1993017666A1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor
09/16/1993CA2131458A1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor
09/15/1993EP0559755A1 Substituted 5-aryl imidazoles
09/15/1993EP0559724A1 Benzofuran and benzthiophene derivatives
09/15/1993EP0559700A1 Novel pilocarpine derivatives and process for their preparation
09/14/1993US5244889 Treatment of cardiovascular disorders
09/08/1993EP0559279A1 Tetrahydropyrimidine derivatives
09/07/1993US5242950 Treatment of macular degeneration
09/07/1993US5242945 Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors
09/07/1993US5242942 Anticonvulsant fructopyranose cyclic sulfites and sulfates
09/07/1993CA1322005C Benzoheterazoles
09/07/1993CA1322004C Pyridyl styrene dialkanoic acids
09/05/1993CA2090170A1 Tetrahydropyrimidine derivatives
09/02/1993WO1993016724A1 Bystander suppression of autoimmune diseases
09/02/1993WO1993016719A2 Use of platelet derived growth factor in ophthalmic wound healing
09/02/1993WO1993016701A2 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
09/02/1993WO1993010141A3 Angiostatic steroids
09/02/1993CA2130748A1 Use of platelet derived growth factor in ophthalmic wound healing
09/01/1993EP0557939A1 Aldose reductase inhibitor
09/01/1993EP0557290A1 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss
09/01/1993EP0316438B1 Chemical prevention or reversal of cataract by phase separation inhibitors
09/01/1993CN1075632A Alkoxylated phenyl and coumarin derivatives and application thereof
08/1993
08/31/1993US5240953 Substituted triazoles as angiotensin ii inhibitors
08/31/1993US5240950 Carbazate derivatives, their production and use
08/31/1993US5240923 Treating glaucoma
08/25/1993EP0556947A1 Use of M1-selective antimuscarinic pyridobenzodiazepinones for the treatment and prevention of axial myopia
08/25/1993EP0556813A1 Amphoteric tricyclic compounds as antihistaminic and antiallergic agents
08/25/1993EP0471718B1 Pharmaceutical composition with a paracetamol base
08/24/1993US5238961 Pgf 1-alcohols and their use as ocular hypotensives
08/24/1993US5238942 Hypotensive agents
08/24/1993US5238932 Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
08/24/1993US5238923 Amino-substituted heterocycles as renin inhibitors
08/19/1993WO1993016068A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
08/19/1993WO1993016067A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity
08/19/1993WO1993015744A1 Bimodal molecular weight hyaluronate formulations and methods for using same
08/19/1993WO1993015608A1 Prevention of retinal injury and degeneration by specific factors
08/19/1993CA2129973A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
08/19/1993CA2129831A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity
08/19/1993CA2129238A1 Bimodal molecular weight hyaluronate formulations and methods for using same
08/18/1993EP0556080A1 Bicyclic pyridine derivatives, process for their preparation, intermediates, their use as medicaments and pharmaceutical compositions containing them
08/18/1993EP0555327A1 Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo
08/18/1993EP0555235A1 Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
08/17/1993US5236951 Administering a phenylethanolamine derivative
08/10/1993US5234927 Magnesium oxide as a biodegradation retarding agent
08/10/1993CA1321199C Chloroaniline derivatives
08/05/1993WO1993014785A1 Immunotherapy for recurrent hsv infections
08/05/1993WO1993014750A2 Amino acids useful as inhibitors of the advanced glycosylation of proteins
08/05/1993WO1993006866A3 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
08/04/1993EP0554107A1 Substituted triazoles as angiotensin II inhibitors
08/04/1993EP0553351A1 CRYSTALLINE MODIFICATION OF HYDROCHLORIDE OF 2-DIMETHYLAMINOETHYL ETHER OF n-BUTYLAMINO BENZOIC ACID, METHOD OF OBTAINING IT AND PHARMACEUTICAL PREPARATION FOR ANESTHESIA OF THE EYE BASED THEREUPON
08/04/1993EP0553263A1 1'-aminospiro-[isoquinoline-4(1h),3'-pyrrolidine]- 1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo
08/04/1993EP0553156A1 Chromans and thiochromans with retinoid-like activity
08/03/1993US5232692 Administering an aqueous solution of povidone-iodine having a specified concentration to the eyes of a human infant to prevent infection by neisseria or chlamydia
08/01/1993CA2088464A1 A new pyridine bicyclic derivatives, process for preparing the same, new intermediates obtained, apllication of the same as drugs, and pharmac eutical compositions containing thesame
07/1993
07/31/1993CA2088347A1 Substituted triazoles as angiotensin ii inhibitors
07/29/1993DE4201554A1 New benzimidazol-1-yl-methyl-bi:phenyl derivs.
07/28/1993EP0552765A1 Benzimidazoles, pharmaceutical compositions containing them and process for their preparation
07/28/1993EP0552282A1 Bi-aromatic compounds and their use in human and veterinary medecine and in cosmetic preparations.
07/28/1993EP0528861A4 Composition and treatment with biologically active peptides and toxic cations
07/28/1993CN1074606A Method of using M1-selective antimuscarinic pyridobenzodiazepinones in axial myopia therapy
07/27/1993US5231096 Anesthetic for central nervous system
07/23/1993CA2087800A1 Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
07/22/1993WO1993014112A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
07/22/1993WO1993014090A1 Heterocyclic compounds and their preparation and use
07/22/1993WO1993014089A1 Heterocyclic compounds and their preparation and use
07/22/1993WO1993014077A1 Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation